Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Apr 1;63(Pt 4):287-90.
doi: 10.1107/S1744309107006719. Epub 2007 Mar 12.

Crystallization and preliminary X-ray crystallographic analysis of the heterodimeric crotoxin complex and the isolated subunits crotapotin and phospholipase A2

Affiliations

Crystallization and preliminary X-ray crystallographic analysis of the heterodimeric crotoxin complex and the isolated subunits crotapotin and phospholipase A2

K F Santos et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. .

Abstract

Crotoxin, a potent neurotoxin from the venom of the South American rattlesnake Crotalus durissus terrificus, exists as a heterodimer formed between a phospholipase A(2) and a catalytically inactive acidic phospholipase A(2) analogue (crotapotin). Large single crystals of the crotoxin complex and of the isolated subunits have been obtained. The crotoxin complex crystal belongs to the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 38.2, b = 68.7, c = 84.2 A, and diffracted to 1.75 A resolution. The crystal of the phospholipase A(2) domain belongs to the hexagonal space group P6(1)22 (or its enantiomorph P6(5)22), with unit-cell parameters a = b = 38.7, c = 286.7 A, and diffracted to 2.6 A resolution. The crotapotin crystal diffracted to 2.3 A resolution; however, the highly diffuse diffraction pattern did not permit unambiguous assignment of the unit-cell parameters.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Photomicrographs of (a) PLA2 and (b) crotapotin crystals.

Similar articles

Cited by

References

    1. Achari, A., Radvanyi, F. R., Scott, D., Bon, C. & Sigler, P. B. (1985). J. Biol. Chem.260, 9385–9387. - PubMed
    1. Arni, R. K., Ward, R. J., Gutierrez, J. M. & Tulinsky, A. (1995). Acta Cryst. D51, 311–317. - PubMed
    1. Baek, S., Kwon, T. K., Lim, J., Lee, Y., Chang, H., Lee, S., Kim, J. & Kwun, K. (2000). J. Immunol.164, 6359–6365. - PubMed
    1. Bon, C. (1982). Toxicon, 2, 105–109. - PubMed
    1. Bon, C., Bouchier, C., Choumet, V., Faure, G., Jiang, M. S., Lambezat, M. P., Radvany, F. & Saliou, B. (1989). Acta Physiol. Pharmacol. Latinoam.39, 439–448. - PubMed

Publication types